“…Using these approaches, fractal dimensionality has been related to inter-individual differences in measures of fluid intelligence (Mustafa et al, 2012; Sandu et al, 2014), IQ (Im et al, 2006), and performance on the cognitive subscale of the Alzheimer’s Disease Assessment Scale (King et al, 2010). Fractal dimensionality has also been shown to differ between healthy adults and a number of patient populations, particularly in Alzheimer’s disease (King et al, 2009, 2010; Thompson et al, 1998) and schizophrenia (Ha et al, 2005; Narr et al, 2004; Nenadic et al, 2014; Sandu et al, 2008; Yotter et al, 2011; Zhao et al, 2016). Thus, while we have demonstrated the benefits of using fractal dimensionality to index age-related differences in subcortical structure, as well as cortical structure (Madan & Kensinger, 2016), the variability of this morphological measure also is related to inter-individual differences in cognitive measures and may hold promise as a biomarker for some neurological disorders.…”